Cargando…
Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands
[Image: see text] In this study, 1H-pyrazole-3-carboxylic acids related to the cannabinoid type 1 (CB1) receptor antagonist rimonabant were amidated with valine or tert-leucine, and the resulting acids were further diversified as methyl esters, amides, and N-methyl amides. In vitro receptor binding...
Autores principales: | Dvorácskó, Szabolcs, Dimmito, Marilisa Pia, Sebastiani, Jessica, La Regina, Giuseppe, Silvestri, Romano, Pieretti, Stefano, Stefanucci, Azzurra, Tömböly, Csaba, Mollica, Adriano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108392/ https://www.ncbi.nlm.nih.gov/pubmed/37077391 http://dx.doi.org/10.1021/acsmedchemlett.3c00024 |
Ejemplares similares
-
Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity
por: Dimmito, Marilisa P., et al.
Publicado: (2019) -
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
por: Mollica, Adriano, et al.
Publicado: (2017) -
Anti-Oxidant and Tyrosinase Inhibitory In Vitro Activity of Amino Acids and Small Peptides: New Hints for the Multifaceted Treatment of Neurologic and Metabolic Disfunctions
por: Luisi, Grazia, et al.
Publicado: (2018) -
On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity
por: Stefanucci, Azzurra, et al.
Publicado: (2019) -
Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)